Silencing CASC11 curbs neonatal neuroblastoma progression through modulating microRNA-676-3p/nucleolar protein 4 like

Zekun Yu1, Jing Zhang1, Jun Han2

  • 1Department of Neonatology, the First Hospital of Jilin University, No. 71, XinMin Street, Changchun, 130021, Jilin, China.

Pediatric Research
|October 24, 2019
PubMed
Abstract

Insights

Long non-coding RNA CASC11 promotes neonatal neuroblastoma by sequestering miR-676-3p, inhibiting NOL4L. Targeting CASC11 offers a potential therapeutic strategy for this cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Neuroblastoma is the most common extracranial solid cancer in neonates.
  • Long non-coding RNA cancer susceptibility 11 (CASC11) is implicated in various cancers, but its role in neonatal neuroblastoma is unclear.

Purpose of the Study:

  • To investigate the role of CASC11 in neonatal neuroblastoma.
  • To elucidate the molecular mechanism of CASC11 in regulating neonatal neuroblastoma progression.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) for gene expression analysis.
  • Cell proliferation, migration, and invasion assays (colony-formation, CCK-8, Transwell, wound-healing).
  • Molecular interaction studies including RNA pull-down, luciferase reporter, and RIP assays.

Main Results:

  • CASC11 expression is significantly upregulated in neonatal neuroblastoma tissues and cells.
  • High CASC11 levels correlate with poor patient survival.
  • CASC11 depletion inhibits proliferation and invasiveness; CASC11 acts as a molecular sponge, releasing NOL4L from miR-676-3p inhibition.

Conclusions:

  • CASC11 promotes neonatal neuroblastoma progression by sequestering miR-676-3p and upregulating NOL4L.
  • CASC11 represents a potential therapeutic target for neonatal neuroblastoma.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K